145 related articles for article (PubMed ID: 26770475)
1. Efficacy of paclitaxel-based doublet regimens combining with intraperitoneal chemotherapy for advanced gastric cancer with peritoneal metastasis.
Chen Y; Tang WF; Lin J; Shi Y; Wang XJ; Chen Q; Guo ZQ
Int J Clin Exp Med; 2015; 8(10):18620-8. PubMed ID: 26770475
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intraperitoneal and intravenous chemotherapy for advanced gastric cancer with peritoneal metastasis.
Chen Y; Wang XJ; Lin RB; Chen L; Lin G; Guo ZQ
Tumori; 2014; 100(5):e180-8. PubMed ID: 25343556
[TBL] [Abstract][Full Text] [Related]
3. Multicenter Retrospective Analysis of Intraperitoneal Paclitaxel and Systemic Chemotherapy for Advanced Gastric Cancer with Peritoneal Metastasis.
Kim DW; Jee YS; Kim CH; Kim JJ; Park S; Choi SI; Park JM; Kim JH;
J Gastric Cancer; 2020 Mar; 20(1):50-59. PubMed ID: 32269844
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment efficacy between adjuvant intravenous chemotherapy and intravenous chemotherapy combined with intraperitoneal perfusion chemotherapy to treat postresection colon cancer.
Jiang T; Feng R; Pan Z; Xu Q; Gao W; Yang S; Chen Q
J Cancer Res Ther; 2018; 14(7):1600-1605. PubMed ID: 30589046
[TBL] [Abstract][Full Text] [Related]
5. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
Kobayashi D; Ishigami H; Kanda M; Tanaka C; Yamaguchi H; Kitayama J; Kodera Y
Oncology; 2020; 98(1):48-52. PubMed ID: 31487733
[TBL] [Abstract][Full Text] [Related]
6. S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.
Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S
Gastrointest Cancer Res; 2012 May; 5(3 Suppl 1):S10-3. PubMed ID: 22876333
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis.
Nakashima T; Arigami T; Uenosono Y; Matsushita D; Shimonosono M; Tsuruda Y; Sasaki K; Baba K; Kurahara H; Ohtsuka T
Int J Clin Oncol; 2023 Oct; 28(10):1371-1377. PubMed ID: 37432613
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
Takashima A; Shitara K; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Kimura Y; Amagai K; Fujii H; Muro K; Esaki T; Choda Y; Takano T; Chin K; Sato A; Goto M; Fukushima N; Hara T; Machida N; Ohta M; Boku N; Shimura M; Morita S; Koizumi W
Gastric Cancer; 2019 Jan; 22(1):155-163. PubMed ID: 29855738
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of different chemotherapy approaches for advanced epithelial ovarian cancer].
Chen YL; Liu YQ; Tang DH; Chu CN
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):110-4. PubMed ID: 18683749
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of paclitaxel combined with S-1 in the prevention and treatment of gastric cancer with peritoneal metastasis].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):979-82. PubMed ID: 26499139
[TBL] [Abstract][Full Text] [Related]
11. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.
Takahashi N; Kanda M; Yoshikawa T; Takiguchi N; Fujitani K; Miyamoto K; Ito Y; Takayama O; Imano M; Mitsumori N; Sakamoto J; Morita S; Kodera Y
Gastric Cancer; 2018 Nov; 21(6):1014-1023. PubMed ID: 29536296
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial.
Shinkai M; Imano M; Chiba Y; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
Anticancer Res; 2018 Oct; 38(10):5975-5981. PubMed ID: 30275228
[TBL] [Abstract][Full Text] [Related]
14. Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report.
Meguro Y; Yamaguchi H; Kitayama J; Kanamaru R; Matsumoto S; Ui T; Haruta H; Kurashina K; Saito S; Hosoya Y; Lefor AK; Sata N
Surg Case Rep; 2020 Mar; 6(1):63. PubMed ID: 32232793
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
Shi C; Yang B; Chen Q; Yang J; Fan N
Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
[TBL] [Abstract][Full Text] [Related]
16. Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial.
Murono K; Nagata H; Ishimaru K; Emoto S; Kaneko M; Hiyoshi M; Sasaki K; Otani K; Shuno Y; Nishikawa T; Tanaka T; Hata K; Kawai K; Nozawa H; Muro K; Ishihara S
Cancer Chemother Pharmacol; 2019 Jan; 83(1):145-150. PubMed ID: 30386886
[TBL] [Abstract][Full Text] [Related]
17. [Multidisciplinary treatment for gastric cancer with peritoneal metastasis].
Ishigami H; Kitayama J; Yamaguchi H; Emoto S; Watanabe T
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2460-3. PubMed ID: 23235165
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy.
Fushida S; Kinoshita J; Oyama K; Fujimura T; Tsukada T; Yamaguchi T; Ninomiya I; Ohta T
Cancer Manag Res; 2018; 10():3833-3839. PubMed ID: 30288114
[TBL] [Abstract][Full Text] [Related]
19. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional chemotherapy combining intraperitoneal docetaxel with intravenous 5-fluorouracil and oxaliplatin for patients with unresectable peritoneal metastasis from gastric cancer: the first study in Western countries.
Lo Dico R; Gornet JM; Guglielmo N; Zaanan A; Taieb J; Pocard M
Pleura Peritoneum; 2020 Jun; 5(2):20190035. PubMed ID: 32566725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
